Following a detailed strategic review, the company has embarked on the creation of a multi-million pound facility to help drive its ambitious growth plans.
The purpose-built premises will more than double Ingenza’s current footprint to approximately 25,000 sqft, expanding its fermentation and research facilities.
Jaymin Amin, Chief Business Officer of Ingenza, explained: “The expansion is a landmark investment for Ingenza, enabling us to increase our fermentation scale to 100L, as well as expanding our research and development labs to support larger programmes."
"Our inGenius platform technology is redefining drug substance development and sustainable biotech manufacturing, and this exciting move will provide an independent, world-class facility to better serve customers worldwide, accelerating our business growth.”
John Mackenzie, Director (Scotland) at Pioneer, said: "We are delighted that Ingenza will be located with us at Edinburgh Technopole. As a UK and world leader in industrial biotechnology, Ingenza is a very welcome addition to Pioneer’s ecosystem."
"Importantly, the business is remaining in the Midlothian Science Zone, while expanding its lab and office operations and creating 50 new highly skilled jobs."
"Ingenza’s growth is hugely positive for our local life sciences cluster, being an exemplar of the Pioneer model of local economic development, partnership and impact that will accelerate scientific discovery.”
